The rate of insulin secretion from isolated rat islets of Langerhans was affected by a number of dihydropyridine derivatives known to interact with voltage-sensitive Ca2+ channels in excitable cells. The channel antagonists nifedipine and nitrendipine were potent inhibitors of glucose-induced insulin secretion in response to both 8 mm-and 20 mM-glucose, although they did not lower the basal secretion rate observed in the presence of 4 mM-glucose. The Ca2+-channel agonist, CGP 28392, also failed to alter the basal rate ofinsulin secretion. In the presence of8 mM-glucose, however, ,tM-CGP 28392 enhanced the insulin-secretion rate to a value approximately double that with 8 mM-glucose alone. This effect was dose-dependent, with half the maximal response elicited by 0.1 M-CGP 28392, and full enhancement at 10 /LM. The response was rapid in onset, with an increase in insulin secretion evident within 2 min of CGP 28392 infusion in perifused islets. Stimulation of insulin secretion by CGP 28392 was correlated with a rapid enhancement of glucose-stimulated 45Ca2+ uptake into islets cells, and with a transiently increased rate of 45Ca2+ efflux from pre-loaded islets. Stimulation of insulin secretion by CGP 28392 was abolished in the presence of noradrenaline, although under these conditions the rapid stimulation of 45Ca2+ influx induced by CGP 28392 was only partially inhibited. In contrast with these results, when islets were incubated in the presence of 20 mM-glucose, CGP 28392 caused a dose-dependent inhibition of insulin secretion. Half-maximal inhibition required approx. 0.2,UM-CGP 28392, with maximal effects observed at 10 /LM. Under these conditions, however, the extent of insulin secretion was still only decreased by about 5000, to a value which was similar to that seen in the presence of 8 mM-glucose and CGP 28392. These results suggest that dihydropyridine derivatives can alter the activity of voltage-dependent Ca2+ channels in islet cells, and are consistent with the possibility that gating of these channels plays an important role in regulating the rate of insulin secretion after glucose stimulation.
INTRODUCTION
The rate of insulin secretion from the B-cells of the endocrine pancreas is believed to be regulated by changes in the cytosolic free Ca2+ concentration ([Ca?I+] ) (see Wollheim & Sharp, 1981 , for review), and direct demonstration that glucose induces a rise in islet-cell [Ca?+] has been provided (Rorsman et al., 1984; Deleers et al., 1985) . Some of the Ca2+ mediating this effect may derive from intracellular pools (Biden et al., 1984) , but the well-documented requirement for extracellular Ca2+ during maintained stimulation of insulin secretion (Curry et al., 1968; Grodsky & Bennett, 1966; Hales & Milner, 1968; Kikuchi et al., 1978; Morgan & Montague, 1984) suggests that influx of Ca2+ from the extracellular medium provides most of the Ca2+ responsible for the rise in [Ca;+] . Indeed, studies of 45Ca2+ fluxes in islet cells have suggested that glucose promotes 45Ca2+ influx within 1 min of stimulation (Wollheim et al., 1977) . This effect has been correlated with changes in islet-cell electrical activity in response to glucose, which produces a characteristic burst of action potentials after membrane depolarization (Dean & Matthews, 1968; Atwater & Beigelman, 1976; Beigelman & Ribalet, 1980) . Removal ofextracellular Ca2+ leads to inhibition ofaction-potential propagation (Dean & Matthews, 1970; Matthews & Sakamoto, 1975) , and it has been suggested that the action potentials represent an inward flow of Ca2+ current (Matthews & Sakamoto, 1975) . On the basis of such observations, the hypothesis has been advanced that the B-cell plasma membrane is equipped with Ca2+-conducting channels whose activity is regulated by the membrane potential. According to this hypothesis, membrane depolarization to a critical threshold potential leads to gating of the Ca2+ channels and net Ca2+ influx (Matthews & Sakamoto, 1975; Wollheim & Sharp, 1981) .
Direct biochemical evidence for the presence of voltage-dependent Ca2+ channels in islet cells is lacking, although studies of the effects of pharmacological agents which affect the functioning of such channels in other tissues have supported the postulate that they are involved in the control of insulin secretion. In particular, the Ca2+-channel antagonists verapamil and D600 have been shown to inhibit glucose-induced insulin release (Devis et al., 1975; Malaisse et al., 1976 ) and 45Ca2+ influx (Malaisse et al., 1976 in islet cells, and the highly potent dihydropyridine class of Ca2+-channel antagonists have also been shown to inhibit glucose-stimulated insulin secretion (Malaisse & Sener, 1981) .
A group of modified dihydropyridine derivatives have been synthesized which have altered properties such that they apparently facilitate Ca2+ inflow through voltagedependent Ca2+ channels in a variety of tissues (Schramm et al., 1983; Erne et al., 1984) . These two reports have appeared which demonstrate that a related compound, BAY K 8644, also enhances glucose-induced insulin release in islets of Langerhans (Malaisse-Lagae et al., 1984; Panten et al., 1985) . EXPERIMENTAL 
Materials
Nifedipine and nitrendipine were donated by Bayer Ltd., Newbury, Berks, U.K., and CGP 28392 was given by Ciba-Geigy, Basle, Switzerland. Di-n-butyl phthalate was purchased from Hopkin and Williams, Chadwell Heath, Essex, U.K., and dinonyl phthalate from BDH Chemicals, Poole, Dorset, U.K. Collagenase was purchased from Boehringer-Mannheim, Lewes, Sussex, U.K., bovine serum albumin (fraction V) from Armour Pharmaceuticals, Eastbourne, Sussex, U.K., and 45Ca2+ and [3H]sucrose were obtained from Amersham International, Amersham, Bucks, U.K. All other reagents were of analytical-reagent quality.
Methods
Isolation of islets of Langerhans. All experiments were performed with islets of Langerhans freshly isolated by collagenase digestion of the pancreas from each of two male Wistar rats (250-300 g) as described in detail by Montague & Taylor (1968) . Islets were isolated and incubated in a bicarbonate-buffered medium, pH 7.4 (Gey & Gey, 1936) , gassed with 02/CO2 (19:1) and containing glucose (4 mM), CaCl2 (2 mM) and bovine serum albumin (1 mg/ml).
Islet incubation conditions. Methods for static incubation and islet perifusion studies of insulin secretion were performed exactly as detailed previously . Islet 45Ca2+-accumulation experiments were performed as described by Morgan & Montague (1982) , and studies of islet-cell 45Ca efflux were undertaken by the methods detailed by . All incubations were carried out at 37°C, and experiments employing nifedipine, nitrendipine and CGP 28392 were performed in the dark. 
RESULTS
The data presented in Fig. 1 demonstrate that nitrendipineandnifedipinebothinducedadose-dependent inhibition of insulin secretion from isolated rat islets of (1 /M) also inhibited insulin secretion in response to 8 mM-glucose, but failed to lower the basal rate of insulin secretion observed in the presence of4 mM-glucose (Table  1 ). In contrast with the effect of nifedipine, CGP 28392
(1 /LM) enhanced the rate of insulin secretion observed in the presence of 8 mM-glucose (Table 1) . This effect was dose-dependent ( Fig. 2) , with half the maximal response observed at 100 nM-CGP 28392 and full enhancement at 10 /LM. Under these conditions the rate ofinsulin secretion was increased to more than double that observed with 8 mM-glucose alone (Fig. 2) . CGP 28392 did not increase the rate of insulin secretion under basal conditions (Table 1) . Perifusion of isolated islets in the presence of 8 mM-glucose and CGP 28392 revealed that the agent caused a prompt increase in insulin secretion, which was evident within 2 min and could be maintained for at least 15 min if CGP 28392 infusion was continued (Fig. 3) .
In contrast with the enhancement of insulin secretion provoked by CGP 28392 when islets were incubated with 8 mM-glucose, exposure of islets to this agent in the presence of 20 mM-glucose was associated with inhibition (Table 1) . This effect was also dose-dependent, but required approx. 200 nM-GCP 28392 for half the maximal response (Fig. 4) . Furthermore, CGP 28392 decreased the rate of glucose-induced secretion by only 46% at concentrations up to 10/uM (Fig. 4) , whereas nifedipine and nitrendipine abolished glucose stimulation when present at 1 ,UM (Fig. 1) .
To examine the possibility that the action of CGP 28392 to stimulate insulin secretion in response to Groups of 100 islets were pre-loaded with 45Ca2+ for 30 min before transfer to perifusion chambers. They were then perifused for 30 min with medium containing 4 mM-glucose, when the glucose concentration was increased to 8 mm. during 10 min of incubation (Table 2) , and the extent of this uptake was markedly enhanced by 1 /tM-CGP 28392.
In addition, CGP 28392 provoked an efflux of 45Ca2+ from pre-loaded islets (Fig. 5 ). This effect was rapid in onset, but was transient, with the rate of 45Ca2+ efflux returning to the control value within 5-6 min. In contrast, when islets were incubated with CGP 28392 in the presence of 20 mM-glucose, the agent markedly inhibited the extent of 45Ca2+ influx (Table 2) . These results are consistent, therefore, with an effect of CGP 28392 to alter islet-cell Ca2+ handling. Incubation ofislets with noradrenaline caused a partial inhibition of CGP 28392-stimulated 45Ca2+ influx (Table  3) , although, under these conditions, the rate of 45Ca2+ influx was still elevated relative to the control value. However, despite-this failure of noradrenaline to abolish the stimulation of 45Ca2+ influx, it completely prevented any stimulation of insulin secretion by CGP 28392 (Table  3) . (10) 851 +77** (10) 
DISCUSSION
The data obtained in the present study demonstrate that a variety of structurally related dihydropyridine derivatives can influence the rate of glucose-induced insulin secretion from isolated rat islets of Langerhans. These agents are believed to exert their influence by specific interaction with voltage-dependent Ca2+ channels located in cell plasma membranes (Braunwald, 1982; Schwartz & Triggle, 1984) . The observation that nifedipine and nitrendipine, inhibitors of voltage-sensitive Ca2+-channel activity, both acted as potent inhibitors of glucose-stimulated insulin secretion ( Fig. 1 ; Malaisse & Boschero, 1977) supports the belief that gating of such channels represents an important component of the stimulus-secretion-coupling mechanism ofthe pancreatic B-cell (Dean & Matthews, 1970; Wollheim et al., 1978; Wollheim & Sharp, 1981) .
In contrast with the inhibitory effects of nifedipine and nitrendipine, the modified analogue CGP 28392 actually enhanced insulin secretion in response to 8 mM-glucose (Table 1; Fig. 2 ). This response was rapid in onset ( Fig.  3 ) and correlated with a rapid stimulation of 45Ca2+ influx into islet cells incubated with CGP 28392 and 8 mM-glucose (Table 2 ). The functional interaction of CGP 28392 with cells has been attributed to binding at a site which is close to the voltage-dependent Ca2+ channel (Erne et al., 1984; Loutzenhiser et al., 1984) , and it has been shown that this interaction induces changes in the properties of the channel. In particular, CGP 28392 increases both the probability ofchannel opening (Brown et al., 1984) and also the mean open time of the channel (Kokubun & Reuter, 1984) . Our results, demonstrating that CGP 28392 promotes 45Ca2+ influx into islet cells (Table 2) , therefore suggest that voltage-sensitive Ca2+ channels are responsible for mediating the enhanced Ca2+ influx seen at sub-maximal glucose concentrations. This conclusion is at variance with that of Lebrun et al. (1982) , who demonstrated that changes in islet-cell Ca2+ fluxes in response to 8.3 mM-glucose are relatively resistant to the Ca2+-channel antagonist verapamil, and suggested therefore that, at low concentrations, glucose facilitates Ca2+ inflow by a voltage-insensitive mechanism. It is unlikely, however, that CGP 28392 facilitated Ca2+ influx by a voltage-insensitive mechanism in our study, since it failed to stimulate insulin secretion at 4 mM-glucose (Table 1) , conditions under which the B-cell membrane is not depolarized, but enhanced secretion at 8 mM-glucose, when membrane depolarization occurs (Atwater & Beigelman, 1976; Ribalet & Beigelman, 1979;  see Wollheim & Sharp, 1981, for review) . Furthermore, nifedipine abolished glucose stimulation at 8 mM-glucose, providing further evidence for the operation of voltagesensitive Ca2+ channels under these conditions. In the study by Lebrun et al. (1982) , islet-cell 45Ca2+-efflux rates were used to estimate indirectly changes in Ca2+ influx, and in the present investigation we have also demonstrated that CGP 28392 transiently facilitates 45Ca2+ efflux from islets perifused in medium containing 8 mM-glucose (Fig.  5) , consistent with the enhancement of Ca2+ influx seen under these conditions ( Table 2) .
Examination of the dose-response characteristics for enhancement of insulin secretion by CGP 28392 (Fig. 2) revealed that approx. 0.1 /tM was required for half the maximal response. This is in good agreement with the dose-response curves for stimulation of 45Ca2+ uptake into neuroblastoma-glioma cells (Freedman & Miller, 1984) and of Ca2+-dependent quin-2 fluorescence in human platelets (Erne et al., 1984) . These observations are consistent, therefore, with the possibility that opening of voltage-sensitive Ca2+ channels plays a primary role in mediating the rise in intracellular free Ca2+ which leads to enhanced insulin secretion at 8 mM-glucose.
The observation that stimulation ofinsulin secretion by CGP 28392 was sensitive to inhibition by noradrenaline (Table 3) suggests that the release of insulin occurred by the normal exocytotic mechanism and was not the result of cell damage caused by CGP 28392. The inhibition of secretion induced by noradrenaline occurred despite an enhanced rate of 45Ca2+ influx in the presence of CGP 28392 (Table 3) , which supports our previous suggestion that noradrenaline does not act primarily to inhibit Ca2+ influx into islet cells, but induces a state of desensitization in the B-cell, whereby a rise in Ca2+ influx is not able to initiate a secretory response .
It has been suggested that gating of voltage-sensitive Ca2+ channels does not contribute to the basal rate of Ca2+ inflow into islet cells, which maintains insulin secretion under resting conditions (Wollheim & Sharp, 1981) . Our results support this idea, since nifedipine blockade failed to lower the basal rate of insulin secretion in the presence of 4 mM-glucose (Table 1) and CGP 28392 did not stimulate secretion under these non-depolarizing conditions (Table 1 ).
An interesting observation arising out of the present (Freedman & Miller, 1984) . Studies of the dose-response relationship for inhibition of insulin secretion in response to 20 mM-glucose revealed that this response was slightly less sensitive to CGP 28392 than was stimulation at 8 mM-glucose (Figs. 2 and 3 ) and that the agent was an order of magnitude less potent as an antagonist than was nitrendipine (Fig. 1) . Furthermore, whereas nitrendipine (1 /LM) abolished glucose-induced insulin secretion, CGP 28392 was still only partially antagonistic at 10 M.
In conclusion, therefore, the results ofthe present study provide further evidence that voltage-sensitive Ca2+ channels play a crucial role in regulating Ca2+ influx and insulin secretion in the pancreatic B-cell, under stimulating conditions. The results also confirm that noradrenaline does not exert its inhibitory effect in the pancreatic B-cell by directly preventing the gating ofvoltage-sensitive Ca2+ channels.
